Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

40.80 -1.73 (-4.07%)
Streaming Delayed Price Updated: 1:09 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 574,404
Open 41.59
Bid (Size) 40.75 (1,100)
Ask (Size) 40.84 (100)
Prev. Close 42.53
Today's Range 40.32 - 43.20
52wk Range 1.865 - 48.26
Shares Outstanding 61,071,897
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗
This clinical-stage biotech develops small-molecule therapies for liver and metabolic diseases, targeting unmet needs in NASH and obesity. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

YTD
+1.7%
+1.7%
1 Month
+10.8%
+10.8%
3 Month
+48.4%
+48.4%
6 Month
+447.7%
+447.7%
1 Year
+1062.4%
+1062.4%

More News

Read More
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
Via Stocktwits
News headline image
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Announces Pricing of Upsized $650 Million Public Offering
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Announces Proposed Public Offering
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades ↗
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Gapping stocks in Monday's session ↗
Via Chartmill

Frequently Asked Questions

Is Terns Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Terns Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Terns Pharmaceuticals, Inc. - Common Stock trade on?
Terns Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock is TERN on the Nasdaq Stock Market
What is the current price of Terns Pharmaceuticals, Inc. - Common Stock?
The current price of Terns Pharmaceuticals, Inc. - Common Stock is 40.80
When was Terns Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Terns Pharmaceuticals, Inc. - Common Stock was at 03/05/26 01:09 PM ET
What is the market capitalization of Terns Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Terns Pharmaceuticals, Inc. - Common Stock is 2.49B
How many shares of Terns Pharmaceuticals, Inc. - Common Stock are outstanding?
Terns Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.